Article

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

2022-09-18

Abstract excerpt

SARS-CoV-2 variants have continuously emerged even as highly effective vaccines have been widely deployed. Reduced neutralization observed against variants of concern (VOC) raises the question as to whether other antiviral antibody activities are similarly compromised, or if they might compensate for lost neutralization activity. In this study, the breadth and potency of antibody recognition and effector function...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 003dc51f-bb84-5f96-b130-78ab426a4669
DOI: 10.1101/2022.09.15.22280000

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populationsDOI 10.1101/2022.09.15.22280000Read

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populationsSemantic proximity Read

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernSemantic proximity Read

Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 VaccinationSemantic proximity Read

Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccinesSemantic proximity Read

Waning and boosting of functional humoral immunity to SARS-CoV-2Semantic proximity Read

A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivitySemantic proximity Read

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformSemantic proximity Read

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domainSemantic proximity Read

Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1Semantic proximity Read

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccinationSemantic proximity Read